Trial Details
RECRUITINGBasic Information
| Clinical ID | c917 |
|---|---|
| Identifier | NCT05815602 |
| Trial Title | Ebastine Versus Mebeverine in IBS Patients |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | IBS - Irritable Bowel Syndrome|IBS |
| Interventions | DRUG: Ebastine|DRUG: Duspatalin |
Participant Information
| Sponsor | Guy Boeckxstaens |
|---|---|
| City | Antwerpen |
| Country/Region | Belgium |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2023-03-30 |
|---|---|
| Primary Completion Date | 2027-10-01 |
| Completion Date | 2028-01-01 |